08th week of 2018 patent applcation highlights part 7 |
Patent application number | Title | Published |
20180049963 | AN ASCORBIC ACID DISPERSION MATERIAL, AND ITS MANUFACTURING METHOD | 2018-02-22 |
20180049964 | PROCESS FOR PROTECTING AND REPAIRING KERATIN FIBRES, BASED ON OXIDIZED POLYSACCHARIDE AND ON (POLY)SACCHARIDE WITH AMINE GROUP | 2018-02-22 |
20180049965 | ORAL CARE METHODS AND COMPOSITIONS UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS | 2018-02-22 |
20180049966 | NAIL COSMETIC MATERIAL AND NAIL ART KIT | 2018-02-22 |
20180049967 | PRODUCT AND METHOD FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS | 2018-02-22 |
20180049968 | INDIVIDUALIZED HAIR TREATMENT | 2018-02-22 |
20180049969 | HAIR CARE COMPOSITIONS COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS | 2018-02-22 |
20180049970 | HAIR CARE COMPOSITIONS COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS | 2018-02-22 |
20180049971 | Multi-Purpose Moisturizer Composition | 2018-02-22 |
20180049972 | CLEANSING COMPOSITION AND METHOD OF MAKING A CLEANSING SOAP | 2018-02-22 |
20180049973 | COSMETIC COMPOSITIONS | 2018-02-22 |
20180049974 | ABUSE-RESISTANT FORMULATIONS | 2018-02-22 |
20180049975 | DRUG DELIVERY DEVICES AND METHODS FOR DRUG DELIVERY | 2018-02-22 |
20180049976 | A TRANSDERMAL DRUG ADMINISTRATION DEVICE | 2018-02-22 |
20180049977 | HYDROGEL MICROPARTICLE SCAFFOLD WITH GRADIENTS OF DEGRADABILITY AND METHODS THEREOF | 2018-02-22 |
20180049978 | METHOD TO ENHANCE SWALLOWING SAFETY AND APPEAL OF BEVERAGES FOR TREATING DYSPHAGIA BASED ON RHEOLOGICAL AND SENSORY PARAMETERS | 2018-02-22 |
20180049979 | LIQUISOFT CAPSULES | 2018-02-22 |
20180049980 | MICROGEL PARTICLES | 2018-02-22 |
20180049981 | PREPARATION OF AN OIL-IN-WATER EMULSION FOR POLYMER STABILIZED PHARMACEUTICAL FORMULATIONS | 2018-02-22 |
20180049982 | CYCLIC PEG COATINGS INCREASE THE BLOOD CIRCULATION TIME OF PARTICLES USED IN DRUG DELIVERY APPLICATIONS | 2018-02-22 |
20180049983 | LIPOSOMAL REHYDRATION SALT FORMULATION AND ASSOCIATED METHODS OF USE | 2018-02-22 |
20180049984 | Carriers for Plasmid and RNP Delivery in the Treatment of Cancer and Other Disease States | 2018-02-22 |
20180049985 | DEPOT FORMULATIONS OF A LOCAL ANESTHETIC AND METHODS FOR PREPARATION THEREOF | 2018-02-22 |
20180049986 | HYDROBROMIDE SALT OF AN ANTI-HIV COMPOUND | 2018-02-22 |
20180049987 | Solid Oral Dosage Forms | 2018-02-22 |
20180049988 | SUSTAINED LOCAL DELIVERY OF DRUGS INCLUDING ANTIBIOTICS | 2018-02-22 |
20180049989 | PHARMACEUTICAL COMPOSITION OF TIZANIDINE AND PROCESS FOR PREPARING THE SAME | 2018-02-22 |
20180049990 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE AND SOLID PREPARATION | 2018-02-22 |
20180049991 | Oligonucleotide Lipid Nanoparticle Compositions, Methods of Making and Methods of Using the Same | 2018-02-22 |
20180049992 | GLYCOSAMINOGLYCAN-COATED METALLIC NANOPARTICLES AND USES THEREOF | 2018-02-22 |
20180049993 | Fibrous dosage form | 2018-02-22 |
20180049994 | TOPICAL REGIONAL NEURO-AFFECTIVE THERAPY WITH CARYOPHYLLENE | 2018-02-22 |
20180049995 | HIF-2-ALPHA INHIBITOR POLYMORPHS | 2018-02-22 |
20180049996 | THERAPEUTIC AGENT FOR CHRONIC RESPIRATORY DISEASE AND COMPOSITION FOR INHIBITING CARDIAC FIBROSIS | 2018-02-22 |
20180049997 | CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITION IN THE TREATMENT OF CANCER | 2018-02-22 |
20180049998 | Naphthoquinone Compounds and Methods for Preparing the Same | 2018-02-22 |
20180049999 | COMPOSITIONS AND METHODS OF TREATMENT OF BREAST DISORDERS AND ESTROGEN-RELATED DISORDERS | 2018-02-22 |
20180050000 | CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG | 2018-02-22 |
20180050001 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH BIGUANIDES | 2018-02-22 |
20180050002 | Solid Solution Compositions and Use in Chronic Inflammation | 2018-02-22 |
20180050003 | Solid Solution Compositions and Use in Chronic Inflammation | 2018-02-22 |
20180050004 | USES OF AND METHODS OF TREATMENT WITH CYSTATHIONINE | 2018-02-22 |
20180050005 | Concentrated Solution of 17-Hydroxydocosahexaenoic Acid | 2018-02-22 |
20180050006 | PURIFIED COMPOSITIONS OF POLYUNSATURATED FATTY ACIDS, THEIR PREPARATION METHOD AND THEIR USE | 2018-02-22 |
20180050007 | METHOD FOR MANUFACTURING LONG CHAIN POLYUNSATURATED FATTY ACID-CONTAINING FAT | 2018-02-22 |
20180050008 | OXYBUTYNIN TRANSDERMAL THERAPEUTIC SYSTEM MUSCARINIC AGONIST COMBINATION | 2018-02-22 |
20180050009 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF WARTS | 2018-02-22 |
20180050010 | Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders | 2018-02-22 |
20180050011 | INFLAMMASOME ACTIVATION IN MYELODYSPLASTIC SYNDROMES | 2018-02-22 |
20180050012 | Method for Inhibiting Growth of Ovarian Cancer Cells | 2018-02-22 |
20180050013 | LIPIDIC FURAN, PYRROLE, AND THIOPHENE COMPOUNDS FOR TREATMENT OF CANCER, NEUROLOGICAL DISORDERS, AND FIBROTIC DISORDERS | 2018-02-22 |
20180050014 | PHARMACEUTICAL COMBINATION COMPRISING METFORMIN AND DIHYDROQUERCETIN AND ITS USE FOR THE TREATMENT OF CANCER | 2018-02-22 |
20180050015 | PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND VE | 2018-02-22 |
20180050016 | COMPOSITIONS AND METHODS TO TREAT NIEMANN-PICK DISEASE | 2018-02-22 |
20180050018 | PERIPHERAL-ANTICHOLINERGIC MUSCARINIC AGONIST COMBINATION | 2018-02-22 |
20180050019 | Melatonin for Preventing and Treating Radiation Vaginitis and Proctitis | 2018-02-22 |
20180050020 | IFETROBAN TREATMENT OF PORTAL HYPERTENSION | 2018-02-22 |
20180050021 | Derivatives of 1-[(cyclopentyl or 2-pyrrolidinyl)carbonylaminomethyl]-4-(1,3-Thiazol-5-yl) benzene which are Useful for the Treatment of Proliferative, Autoimmune or Inflammatory Diseases | 2018-02-22 |
20180050022 | FACTOR XIa INHIBITORS | 2018-02-22 |
20180050023 | OXYBUTYNIN-XANOMELINE TRANSDERMAL THERAPEUTIC SYSTEM COMBINATIONS | 2018-02-22 |
20180050024 | 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS | 2018-02-22 |
20180050025 | PIPERIDINE-2, 6-DIONE DERIVATIVES AND THEIR USE AS TUMOR NECROSIS FACTOR INHIBITORS | 2018-02-22 |
20180050026 | METHODS FOR STABILIZING OXIDATIVELY UNSTABLE COMPOSITIONS | 2018-02-22 |
20180050027 | TREATMENT OF PEMPHIGUS | 2018-02-22 |
20180050029 | SELECTIVE CONNEXIN HEMICHANNELS BLOCKERS FOR THE TREATMENT OF EPILEPSY | 2018-02-22 |
20180050030 | COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT | 2018-02-22 |
20180050031 | Treatment of Multiple Sclerosis With Combination of Laquinimod and Dimethyl Fumarate | 2018-02-22 |
20180050032 | TEMOZOLOMIDE POWDER FORMULATION | 2018-02-22 |
20180050033 | ANTIFUNGAL TREATMENT OF RHEUMATOID ARTHRITIS | 2018-02-22 |
20180050035 | ANTIFUNGAL TREATMENT OF ROSACEA | 2018-02-22 |
20180050036 | CML THERAPEUTIC AGENTS WITH REDUCED DRUG-RESISTANCE AND SIDE-EFFECT COMPRISING 1,6-DISUBSTITUTED INDOLE COMPOUNDS | 2018-02-22 |
20180050037 | ALK KINASE INHIBITOR AND ITS USE | 2018-02-22 |
20180050038 | ERBB4 INHIBITORS AND METHODS OF USE THEREOF | 2018-02-22 |
20180050039 | INDUCTION OF TUMOR HYPOXIA FOR CANCER THERAPY | 2018-02-22 |
20180050040 | USE OF 4-(4-FLUORO-2-METHOXYPHENYL)-N--1,3,5-TRIAZIN-2-AMINE FOR TREATING LYMPHOMAS | 2018-02-22 |
20180050041 | Compositions and Methods for Treating Niemann Pick C Disease | 2018-02-22 |
20180050042 | Novel Formulation of Meloxicam | 2018-02-22 |
20180050044 | COBALT-POLYPYRIDYL COMPLEX FOR TREATMENT OF CANCER, A PHARMACEUTICAL COMPOSITION AND A KIT COMPRISING IT | 2018-02-22 |
20180050045 | METHOD FOR INHIBITING THE EXPRESSION OF ABC TRANSPORTER PROTEIN | 2018-02-22 |
20180050046 | FULVESTRANT FORMULATIONS | 2018-02-22 |
20180050047 | CORTEXOLONE 17alpha-PROPIONATE FOR USE IN THE TREATMENT OF SKIN WOUNDS AND/OR ATROPHIC SKIN DISORDERS | 2018-02-22 |
20180050048 | CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF | 2018-02-22 |
20180050049 | COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES | 2018-02-22 |
20180050050 | FRANKIAMICIN A COMPOSITIONS AND METHODS | 2018-02-22 |
20180050051 | FUMAGILLOL DERIVATIVES | 2018-02-22 |
20180050052 | NEPRILYSIN INHIBITORS | 2018-02-22 |
20180050053 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2018-02-22 |
20180050054 | Administration of Nicotinamide Mononucleotide in the Treatment of Disease | 2018-02-22 |
20180050055 | Exploiting nutrient deprivation for modulation of glycosylation - research diagnostic, therapeutic, and biotechnology applications | 2018-02-22 |
20180050056 | CONJUGATE INCLUDING CORE AND SIALIC ACID OR DERIVATIVE THEREOF BOUND TO SURFACE OF CORE AND USE THEREOF | 2018-02-22 |
20180050057 | CRYSTAL-WATER-FREE CALCIUM DIBUTYRYLADENOSINE CYCLOPHOSPHATE CRYSTAL FORM AND PREPARATION METHOD AND APPLICATION THEREOF | 2018-02-22 |
20180050058 | NUCLEIC ACID APTAMER SPECIFICALLY BINDING TO AVIAN INFLUENZA VIRUS SUBTYPE H5 AND METHOD OF DETECTING AVIAN IFLUENZA VIRUS SUBTYPE H5 USING THE SAME | 2018-02-22 |
20180050059 | DELIVERY OF RNA TO DIFFERENT CELL TYPES | 2018-02-22 |
20180050060 | PREECLAMPSIA | 2018-02-22 |
20180050061 | RONEPARSTAT COMBINED THERAPY OF MULTIPLE MYELOMA | 2018-02-22 |
20180050062 | DIALYSIS PRECURSOR COMPOSITION PRODUCT | 2018-02-22 |
20180050063 | METHODS OF MEDIATING MACROPHAGE PHENOTYPES | 2018-02-22 |
20180050064 | METHOD FOR PRODUCING EYE DROPS | 2018-02-22 |
20180050065 | CHIMERIC ANTIGEN RECEPTOR | 2018-02-22 |
20180050066 | SURGICAL WOUND HEALING COMPOSITION AND METHOD OF APPLYING THE SAME | 2018-02-22 |